Trial intelligence / Profile preview

Tocilizumab plus methotrexate versus tocilizumab monotherapy in mild to moderate rheumatoid arthritis with inadequate response to methotrexate

2011-001863-39Phase 3Completed

Sponsor

Roche

Start

Jun 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1